SEE FULL CALENDAR
To facilitate research activities, the Dean’s Office of the the David Geffen School of Medicine at UCLA (DGSOM) provides funding and support to basic departments, clinical departments, institutes, and centers. Learn more about departments, institutes, and centers →
The Dean’s Office collaborates with these entities to recruit and retain outstanding faculty.
Additionally, the DGSOM supports a number of research initiatives and activities, including:
To advance the diagnosis and treatment of diseases, the DGSOM supports the UCLA Institute for Precision Health, an initiative that promotes development in genetic and genomic medicine and uncovers opportunities for innovative discovery.
Visit the Website
The DGSOM invests in scientific collaboration through six Unified Research Themes, established to stimulate interaction between UCLA’s top scientists and clinicians. The themes focus on the following areas:
The David Geffen School of Medicine at UCLA (DGSOM) supports the pursuit of innovative ideas that lead to major advances in knowledge and patient care. Financial support from the institution advances scientific excellence at defined stages of a research project or research career. As such, the DGSOM Dean’s Office has established multiple funding opportunities to provide resources, on a competitive basis, that advance outstanding research at critical inflection points. To increase efficiency, a consolidated application process and portal has been established for many of these funding opportunities.
The DGSOM established seed grant programs to fund new ideas or promote new collaborations that are either insufficiently developed or too risky to be competitive for extramural funding. Most seed grants will center around the six Unified Research Themes, which have been identified as broad priority areas for DGSOM investment. The application process will be centralized and coordinated, with a common application structure.
Seed grant opportunities are also available for research that does not fit into a Unified Research Theme. Reviewers will consider applications from all biomedical or medical research areas that could benefit from pioneering teamwork. Applications without an associated Research Theme may be directed to one.
The DGSOM established the IP Accelerator to support the advancement of translational research findings with potential commercial value. Due to funding limitations, researchers often license advances to biotechnology or pharmaceutical companies at the earliest stages of development. Early licensing limits the financial return to the investigator and the university and allows companies to terminate a promising project due to strategic decisions unrelated to potential impact on patient health.
The DGSOM hopes to advance the development of promising discoveries so that the commercial value increases and the clinical value becomes apparent, prior to licensing.
Applications submitted for IP Accelerator funding will be evaluated for both scientific and commercial merit. Progress of funded projects will be continually evaluated. If the project advances as expected and continues to show progress, the investigator will receive commercialization support from the UCLA Technology Development Group (TDG).
Mission and Contacts:
An important mission of the David Geffen School of Medicine is to support the advancement of translational research findings with potential commercial value. Due to funding limitations, it is often necessary to license research advances to biotechnology or pharmaceutical companies at the earliest stages of development, causing a loss of control and often curtailing further developmentof the discovery. Worst of all, this loss of control leads to missed opportunities for improving patient health.
The DGSOM established the IP Accelerator to:
The mission of the DGSOM Accelerator is to allow early-stage discoveries to advance to the next stage. Projects will be selected by an open Request for Applications. These applications will be subject to expert review for scientific merit and commercial/business potential.
The Accelerator will be run by Dr. Judith Gasson, Professor Emeritus of Medicine and Biological Chemistry, past Director of the Jonsson Comprehensive Cancer Center, and past Senior Associate Dean for Research of the DGSOM.
The Director will:
For more information, please contact Nancy Presseau from the UC BRAID Center for Accelerated Innovation
The Center for Accelerated Innovation (CAI) is a National Heart, Lung, and Blood Institute (NHLBI)-funded initiative coordinated by the University of California Biomedical Research Acceleration, Integration, and Development (UC BRAID) consortium, with Dr. Michael Palazzolo in the DGSOM’s Department of Medicine as Principal Investigator and Director. Like UCLA’s IP Accelerator, the CAI evaluates projects on the basis of both scientific and commercial value. Funded projects receive close business development and commercialization guidance by a team of experts with years of experience in the biotechnology industry.
CONTENT COMING: Biltong chuck picanha ball tip turducken, pork loin beef buffalo kielbasa pig pork capicola andouille jerky. Bacon brisket strip steak meatball cow, tenderloin picanha spare ribs ground round corned beef. Turkey landjaeger meatloaf tri-tip, short loin ground round jowl bacon. Hamburger fatback picanha pork chop, buffalo prosciutto tri-tip pig. Chuck rump doner cupim beef ribs sirloin alcatra biltong leberkas boudin ball tip. Sirloin tenderloin landjaeger chuck drumstick pork loin short loin.
The effort to improve health and healthcare relies on the training and development of accomplished physician-scientists. The DGSOM offers students and faculty a variety of training opportunities that stimulate both professional and personal growth.
The DGSOM Shared Resources allow the community to access mission-critical tools that might be unaffordable or inaccessible to individuals. The DGSOM Dean’s Office supports* the following services:
*Many of the shared resources independently run on the Sales & Service model.
The UCLA Clinical and Translational Science Institute (CTSI), a research partnership, transforms research into improvements in health care, disease prevention, and treatment in Los Angeles. As part of that mission, the CTSI offers a variety of researcher resources, including:
QUESTION: Will you provide links for the Translational Oncology Research Lab and Therapeutic Antibody Initiative (if they have them)?
The staff at UCLA believe that good science is safe science. The DGSOM Research Safety Officehelps researchers adhere to safety requirements and offers a variety of safety resources, including those related to working with:
The DGSOM research awards recognize accomplished investigators for remarkable work. Additionally, the awards provide the financial support researchers need to pursue breakthroughs that will help solve pressing biomedical challenges and improve lives.